secwatch / observer
8-K filed October 10, 2023, 7:59 PM ET ticker TLPH CIK 0001427925
other material confidence high sentiment neutral materiality 0.35

AcelRx shareholders approve 1.5M share increase to 2020 equity plan; elect three directors

TALPHERA, INC.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

TALPHERA, INC. shareholders approved Approval of amendment and restatement of the Amended and Restated 2020 Equity Incentive Plan at the 2023-10-10 meeting.

Proposal
equity plan
Outcome
passed
Meeting
2023-10-10
Exact text from the filing
Proposal No. 4 The Company’s Amended and Restated 2020 Equity Incentive Plan was approved, by the following vote: For Against Abstain 6,562,640 486,414 35,579
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

TALPHERA, INC. shareholders approved Advisory vote on executive compensation at the 2023-10-10 meeting.

Proposal
say on pay
Outcome
passed
Meeting
2023-10-10
Exact text from the filing
Proposal No. 3 The compensation paid to the Company’s named executive officers
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

TALPHERA, INC. shareholders approved Election of Class III Directors at the 2023-10-10 meeting.

Proposal
director election
Outcome
passed
Meeting
2023-10-10
Exact text from the filing
Nominee For Withheld Marina Bozilenko 6,746,727 337,906 Howard B. Rosen 6,691,709 392,924 Mark Wan 6,724,271 360,362
View on SEC.gov

Browse all shareholder votes →

TALPHERA, INC. filing history →

Source: SEC EDGAR
accession 0001437749-23-027971
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.